Steven Cohen Point72 Asset Management
Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$284M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$243M |
| 3 |
Eli Lilly
LLY
|
+$204M |
| 4 |
Meta Platforms (Facebook)
META
|
+$191M |
| 5 |
Microsoft
MSFT
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$205M |
| 2 |
Merck
MRK
|
+$169M |
| 3 |
Canadian National Railway
CNI
|
+$131M |
| 4 |
NXP Semiconductors
NXPI
|
+$119M |
| 5 |
Fidelity National Information Services
FIS
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.77% |
| 2 | Technology | 20.47% |
| 3 | Consumer Discretionary | 13.53% |
| 4 | Financials | 8.97% |
| 5 | Communication Services | 7.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LPRO
226
DELISTED
Open Lending Corp
LPRO
| $24.9M | 0.13% |
+974,523
| New | +$19M |
|
227
PepsiCo
PEP
$198B
| $24.8M | 0.13% |
179,040
-205,561
| -53% | -$28M |
|
|
PPLI
228
People Inc
PPLI
$2.89B
| $24.7M | 0.13% |
+378,001
| New | +$25.9M |
|
|
SKX
229
DELISTED
Skechers
SKX
| $24.6M | 0.13% |
812,600
-115,525
| -12% | -$3.44M |
|
230
Microchip Technology
MCHP
$40.1B
| $24.4M | 0.12% |
474,962
-191,550
| -29% | -$9.97M |
|
231
Huazhu Hotels Group
HTHT
$14.9B
| $23.9M | 0.12% |
553,136
+440,348
| +390% | +$17.2M |
|
232
Deckers Outdoor
DECK
$12.4B
| $23.9M | 0.12% |
651,492
-506,616
| -44% | -$17.5M |
|
233
Acadia Pharmaceuticals
ACAD
$5.1B
| $23.9M | 0.12% |
578,195
+379,685
| +191% | +$16.4M |
|
234
LivaNova
LIVN
$4.32B
| $23.8M | 0.12% |
525,940
-97,397
| -16% | -$4.71M |
|
235
Incyte
INCY
$25.9B
| $23.4M | 0.12% |
+261,011
| New | +$25.2M |
|
236
Omnicell
OMCL
$1.58B
| $23.4M | 0.12% |
+313,526
| New | +$21.7M |
|
237
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$46.7B
| $23.2M | 0.12% |
+142,000
| New | +$23.6M |
|
238
DuPont de Nemours
DD
$18.4B
| $23.1M | 0.12% |
331,824
+149,814
| +82% | +$10.5M |
|
239
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.6B
| $23.1M | 0.12% |
275,000
+125,000
| +83% | +$10.5M |
|
240
Linde
LIN
$224B
| $23M | 0.12% |
+96,500
| New | +$23.4M |
|
241
Arrow Electronics
ARW
$10.4B
| $22.9M | 0.12% |
+291,601
| New | +$21.5M |
|
242
Pacific Biosciences
PACB
$392M
| $22.8M | 0.12% |
+2,311,631
| New | +$13.3M |
|
243
APA Corp
APA
$14.8B
| $22.7M | 0.12% |
2,399,499
+710,650
| +42% | +$9.73M |
|
244
Replimune Group
REPL
$1.41B
| $22.7M | 0.12% |
+986,916
| New | +$22.5M |
|
245
Roku
ROKU
$23.5B
| $22.6M | 0.12% |
119,498
+50,380
| +73% | +$7.97M |
|
246
Equitable Holdings
EQH
$13.4B
| $22.3M | 0.11% |
1,222,396
-4,086,826
| -77% | -$82.2M |
|
247
Alkermes
ALKS
$8.16B
| $22.3M | 0.11% |
1,343,911
-1,879,707
| -58% | -$34.2M |
|
248
Canadian Natural Resources
CNQ
$104B
| $22.1M | 0.11% |
2,817,155
-5,637,387
| -67% | -$50.8M |
|
249
Green Dot
GDOT
$766M
| $22.1M | 0.11% |
436,934
+109,784
| +34% | +$5.63M |
|
|
CCMP
250
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $22.1M | 0.11% |
+154,649
| New | +$23.1M |
|
Similar funds
Steven Cohen's Q3 2020 Portfolio in Review
As of Q3 2020, Steven Cohen held 1,184 positions worth $19.5B, up 27% from $15.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Steven Cohen deployed $3.06B of net new capital in Q3 2020, opening 406 new positions and adding to 253 existing holdings. Its largest new stake was Palantir: 29,904,230 shares worth $284M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Immunomedics Inc, an estimated $205M trimmed.
- Steven Cohen's largest Q3 2020 buy was Palantir: 29,904,230 shares worth $284M.
- Steven Cohen added most to Alphabet (Google) Class A in Q3 2020, an estimated $243M increase.
- Steven Cohen's biggest Q3 2020 reduction was Immunomedics Inc, cutting an estimated $205M.
- Steven Cohen fully exited Salesforce in Q3 2020, selling an estimated $105M.
- Steven Cohen's ten largest holdings make up 16% of its $19.5B portfolio in Q3 2020.
- Steven Cohen opened 406 new positions and closed 288 in Q3 2020.
- Steven Cohen's portfolio value rose 27% quarter-over-quarter to $19.5B.
Based on Point72 Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.